Gregory J Gatto is a notable inventor based in Winston-Salem, NC (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 3 patents. His work focuses on developing novel compounds that have potential therapeutic applications.

Latest Patents

Gatto's latest patents include innovative formulations and methods related to specific chemical compounds. One of his notable inventions is the patent for (2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide novel salt forms. This invention relates to methods for treating various conditions associated with dysfunction of the central and autonomic nervous systems. Another significant patent is for the synthesis and novel salt forms of (R)-3-((E)-pyrrolidin-3-yl)vinyl)-5-tetrahydropyran-4-yloxy)pyridine. This invention focuses on processes for the commercial-scale production of these compounds, ensuring they meet the necessary purity and quality for pharmaceutical use.

Career Highlights

Gregory J Gatto is currently associated with Targacept, Inc., where he continues to advance his research in pharmaceutical innovations. His work has been instrumental in developing new therapeutic agents that can address complex medical conditions.

Collaborations

Gatto has collaborated with several professionals in his field, including Gary Maurice Dull and Julio A Munoz. These collaborations have contributed to the successful development of his patented inventions.

Conclusion

Gregory J Gatto is a prominent figure in pharmaceutical chemistry, with a focus on innovative compounds that hold promise for treating various medical conditions. His contributions through patents and collaborations highlight his commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.